SymBio Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.6%.

Top 19 shareholders own 15.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.01%	Rakuten Investment Management, Inc.	1,836,600	JP¥299.4m	-12.7%	0.16%
2.58%	Fuminori Yoshida	1,179,700	JP¥192.3m	0%	no data
2.18%	Heights Capital Management, Inc.	1,000,000	JP¥163.0m	0%	0.64%
1.33%	Norihiro Kuroda	610,000	JP¥99.4m	-13.4%	no data
0.94%	Sukenori Ito	430,000	JP¥70.1m	0%	no data
0.65%	Daisuke Gomi	300,000	JP¥48.9m	0%	no data
0.59%	Matsui Securities Co. Ltd., Asset Management Arm	271,000	JP¥44.2m	8.31%	0.21%
0.56%	SBI Holdings Inc., Asset Management Arm	255,980	JP¥41.7m	-34.1%	0.02%
0.48%	Toshitaka Kashiwabara	220,025	JP¥35.9m	0%	no data
0.34%	Daiwa Asset Management Co., Ltd.	155,250	JP¥25.3m	0%	no data
0.27%	Sumitomo Mitsui Financial Group Inc., Asset Management Arm	125,200	JP¥20.4m	0%	no data
0.27%	Herald Investment Management Ltd.	121,579	JP¥19.8m	0%	0.01%
0.26%	Tsuguyuki Fujimoto	121,000	JP¥19.7m	0%	no data
0.26%	Hiroshi Nishioka	120,000	JP¥19.6m	0%	no data
0.25%	Hiromi Toshishige	115,800	JP¥18.9m	0%	no data
0.13%	State Street Global Advisors, Inc.	60,200	JP¥9.8m	-4.44%	no data
0.076%	Dimensional Fund Advisors LP	34,800	JP¥5.7m	0%	no data
0.049%	Shigetoshi Matsumoto	22,500	JP¥3.7m	0%	no data
0.044%	Nomura Holdings Inc, Securities & Investment Arm	20,074	JP¥3.3m	-92.6%	no data